×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Confident Abivax aims to disrupt IBD landscape
The Pharma Letter
Marc de Garidel, chief executive of French clinical-stage biotech Abivax (Nasdaq: ABVX), has good reason for his belief in the company's...
1 day ago
Abivax Advances Ulcerative Colitis Candidate with U.S. IPO
Genetic Engineering and Biotechnology News
Abivax envisions obefazimod as a first-line treatment for UC and Crohn's disease after failure of conventional treatments. That's a sweet spot...
6 months ago
Abivax SA Announces Upcoming General Meeting - TipRanks.com
Tipranks
Abivax SA Sponsored ADR (ABVX) has released an update. Abivax SA, a biotech firm focusing on therapeutics for chronic inflammatory diseases, has announced...
6 days ago
Dechert Advises Abivax on Largest-ever Nasdaq IPO fo...
Dechert LLP
Dechert advised French biotech Abivax in connection with its successful IPO on the Nasdaq Global Market (“Nasdaq”) for €223.3 million...
6 months ago
ABIVAX Société Anonyme (NASDAQ:ABVX) Short Interest Update
Defense World
ABIVAX Société Anonyme (NASDAQ:ABVX – Get Free Report) was the target of a significant decrease in short interest in April.
3 days ago
Latham Watkins Advises on Abivax IPO on the Nasdaq Global Market
Latham & Watkins LLP
The offering price was set at US$11.60 per ADS in the US Offering and a corresponding offering price of €10.9864 per ordinary share based on an...
6 months ago
Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Sponsorship of Scientific ...
Yahoo Finance
Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Sponsorship of Scientific Symposium at The 19th...
3 months ago
Is ABIVAX Société Anonyme (EPA:ABVX) A Risky Investment?
Simply Wall Street
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when...
3 weeks ago
Abivax Adds $236M to Show Its Anti-Inflammatory Med Can Stand Apart in Crowded Field
MedCity News
Obefazimod is a small molecule designed to enhance expression of miR-124, a micro-RNA that plays a role in regulating the inflammatory response.
6 months ago
Short Interest in ABIVAX Société Anonyme (NASDAQ:ABVX) Declines By 43.0%
MarketBeat
ABIVAX Société Anonyme (NASDAQ:ABVX - Get Free Report) was the recipient of a large decrease in short interest in the month of April.
2 days ago